Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) Return on Invested Capital (2022 - 2024)

Century Therapeutics has reported Return on Invested Capital over the past 3 years, most recently at 3.46% for Q4 2024.

  • Quarterly Return on Invested Capital rose 346.0% to 3.46% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 3.46% through Dec 2024, up 346.0% year-over-year, with the annual reading at 0.0% for FY2025, 285.0% down from the prior year.
  • Return on Invested Capital was 3.46% for Q4 2024 at Century Therapeutics, up from 0.01% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 3.46% in Q4 2024 and troughed at 0.01% in Q1 2024.
  • The 3-year median for Return on Invested Capital is 0.01% (2023), against an average of 0.38%.
  • Year-over-year, Return on Invested Capital changed 0bps in 2023 and then soared 346bps in 2024.
  • A 3-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then tumbled by -77bps to 0.01% in 2023, then soared by 47094bps to 3.46% in 2024.
  • Per Business Quant, the three most recent readings for IPSC's Return on Invested Capital are 3.46% (Q4 2024), 0.01% (Q3 2024), and 0.01% (Q2 2024).